Order Book analysis by شرکت داروسازی فارابی about Stock هجرت: Buy recommendation (8/13/2025)
https://sahmeto.com/message/3707471
شرکت داروسازی فارابی
Rank: 557
Analytical Power:
2.1
Farabi Pharmaceutical Company bought 4615.478 million shares of Hijra on 22/05/22 and currently holds 24.228 % of Hijra's shares in its portfolio.
Translated from: Farsi
Show Original Message
Signal Type: Buy
Source Message:
Price at Publish Time:
32,900